LncRNA H19 Promotes Gastric Cancer Metastasis via miR‐148‐3p/SOX‐12 Axis

Author:

Zhang Xin,Wang Ge,Li Xiaoru,Liu Yanqing,Wu Xue,Zhou Yazhe,Liu Jie,Wang Haiying,Jiao Rui,Chen YingORCID,Wang QiangORCID

Abstract

Background. Gastric cancer (GC) is the most common malignant tumor and ranks third in the world. LncRNA H19 (H19), one of the members of lncRNA, is overexpressed in various tumors. However, many undetermined molecular mechanisms by which H19 promotes GC progression still need to be further investigated. Methodology. A series of experiments was used to confirm the undetermined molecular mechanism including wound healing and transwell assays. Key Results. In this study, a significant upregulation of H19 expression was detected in GC cells and tissues. The poor overall survival was observed in GC patient with high H19 expression. Overexpression of H19 promoted the migration of GC cells, while knockdown of H19 significantly inhibited cell migration. Moreover, miR‐148a‐3p had a certain negative correlation with H19. Luciferase reporter assay confirmed that H19 could directly bind to miR‐148a‐3p. As expected, miR‐148a mimics inhibited cell migration and invasion induced by H19 overexpression. The above findings proved that H19 functions as a miRNA sponge and verified that miR‐148a‐3p is the H19‐associated miRNA in GC. We also confirmed that SOX‐12 expression was upregulated in GC patient’s samples. SOX‐12 expression was positively correlated with expression of H19 and was able to directly bind to miR‐148a‐3p. Importantly, in vitro wound healing assay showed that knockout of SOX‐12 could reverse the promoting effect of H19 overexpression on cell migration. Conclusion. In conclusion, H19 has certain application value in the diagnosis and prognosis of GC. Specifically, H19 accelerates GCs to migration and metastasis by miR‐138a‐3p/SOX‐12 axis.

Funder

Key Research and Development Projects of Shaanxi Province

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3